The latest consensus on the diagnosis and management of prolactin-secreting pituitary adenomas recommends that pituitary surgery along with dopamine agonist therapy should be considered as a first-line treatment option in patients with microprolactinoma [15]. The gene discussed is PRL; the disease is Microprolactinoma.